ArticleEpigenetics2022

Tumour suppressor TET2 safeguards enhancers from aberrant DNA methylation and epigenetic reprogramming in ERα-positive breast cancer cells.

Ruitu Lyu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.